Skip to content

A study on reducing the incidence of postherpetic neuralgia

A study on reducing the incidence of postherpetic neuralgia by epidural injection of medical ozone through intervertebral foramen

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084014
Enrollment
Unknown
Registered
2024-05-09
Start date
2024-05-13
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Herpes zoster neuralgia

Interventions

experimental group:Medical ozone intervertebral foramen epidural injection
Control group:False injection

Sponsors

Deyang People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Men or women aged = 18 years with a history of herpes zoster = 90 days; 2. Involving spinal nerves (/thoracic/lumbar nerves); 3. The score on the Digital Rating Scale (NRS-11) is = 4 points 4. Voluntarily sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1.Refusal to participate in this experiment; 2. Individuals with ozone allergies; 3. Patients with fava bean disease; 4. Pregnant or lactating women; 5. Patients with hyperthyroidism; 6. Patients with sickle cell anemia; 7. Generally, the condition is poor and cannot be treated; 8. Coagulation dysfunction, use of anticoagulants, or platelet count<70 × 10 ^ 9/l; 9. Patients with hemochromatosis or those receiving copper/iron therapy; 10. Intellectually unable to complete self-evaluation questionnaires; 11. Other situations where the researcher deems it inappropriate to enter the experiment.

Design outcomes

Primary

MeasureTime frame
The incidence of postherpetic neuralgia;

Secondary

MeasureTime frame
Patient Gender;Patient age;Hospitalization days;Ultrasound guided paraspinal nerve block treatment frequency;CT guided treatment frequency;Pain digital scores at 1 week, 2 weeks, 1 month, 2 months, 3 months, and 6 months after herpes zoster;

Countries

China

Contacts

Public ContactDongmei Xiang

Deyang People's Hospital

xdm661437@163.com+86 158 8116 8542

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026